Antibody to TNF receptor-like molecules
US7569387B2 · kind B2 · utility
3Cited by
5References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 17, 2006 |
| Grant date | Aug 4, 2009 |
| Priority date | — |
| Expiry date | Dec 1, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2799/021
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel MK61 polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, selective binding agents, and methods for producing MK61 polypeptides. Also provided for are methods for the treatment, diagnosis, amelioration, or prevention of diseases with MK61 polypeptides.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.